yh 439 has been researched along with vinyl carbamate in 1 studies
| Studies (yh 439) | Trials (yh 439) | Recent Studies (post-2010) (yh 439) | Studies (vinyl carbamate) | Trials (vinyl carbamate) | Recent Studies (post-2010) (vinyl carbamate) |
|---|---|---|---|---|---|
| 21 | 0 | 2 | 69 | 0 | 7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, SG; Lee, JW; Liem, A; Miller, JA; Sohn, Y; Surh, YJ; Yoo, JK | 1 |
1 other study(ies) available for yh 439 and vinyl carbamate
| Article | Year |
|---|---|
Inhibition of vinyl carbamate-induced hepatotoxicity, mutagenicity, and tumorigenicity by isopropyl-2-(1,3-dithietane-2-ylidene)-2-[N-(4-methylthiazol-2- yl)carbamoyl]acetate (YH439).
Topics: Animals; Anticarcinogenic Agents; Carcinogens; Cytochrome P-450 CYP2E1; Down-Regulation; Female; Liver; Liver Neoplasms, Experimental; Male; Mice; Rats; Rats, Sprague-Dawley; Thiazoles; Urethane | 1998 |